Effect of Schistosoma mansoni infection and treatment on drug metabolizing enzymes

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 9, 2000, Pages 867-874

  Ebeid, F A ^a   Seif El Din, S H ^a   Ezzat, A R ^a  

^a THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

Alanine aminotransferase; CAS 55268 74 1; Praziquantel, drug metabolizing enzymes; Schistosomiasis mansoni

Indexed keywords

CAS 55268 74 1; CYTOCHROME B5; CYTOCHROME P450; DRUG METABOLIZING ENZYME; PRAZIQUANTEL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; LIVER FUNCTION TEST; MALE; MOUSE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TREATMENT OUTCOME; ULTRACENTRIFUGATION;

EID: 0033805151     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300304     Document Type: Article

References (29)

1. Alkaline phosphatase isoenzymes abnormalities in hepatic schistosomiasis
2. Sonographic studies of school children in a village endemic for S. mansoni
3. A preliminary report on the prognostic value of selected diagnostic enzymes among certain malignant and schistosomal malignant patients
4. The effect of praziquantel treatment on the liver functions, worm burden and granuloma size using two drug regimen in murine S. mansoni infection
5. Possible mechanisms of alteration in the capacity of carcinogen-metabolizing enzymes during schistosomiasis
6. Effect of specific chemotherapy on serum enzymes in patients with schistosomiasis
7. Effect of Halothane or Enflurane on hepatic functions and ultrastructure of the liver in murine schistosomiasis
8. Hepatic cytochrome P-450 system in experimental hepatosplenic schistosomiasis
9. Schistosoma mansoni eggs as a target for praziquantel: Efficacy of oral application in mice
10. Influence of S. mansoni infection on carcinogen-metabolizing capacities and in vitro aflatoxin B1 metabolism in human liver
11. Liver and biliary tract disease
12. Protein measurement with Folin-phenol reagent
13. Studies on the mechanism of microsomal triphosphopyridine-nucleotide cytochrome C reductase
14. Effect of schistosomiasis infection on the clearance of phenazone in mice
15. Effect of praziquantel on mice repeatedly infected with S. mansoni
16. Impact of drug dosage and brand on bioavailability and efficacy of praziquantel
17. Alteration in the carcinogen-metabolizing capacities of mouse liver during S. mansoni infection
18. An efficient method for exposure of mice to cercariae of S. mansoni
19. The carbon monoxide-binding pigment of liver microsomes. I-Evidence for its haemoprotein nature
20. New approach to the screening of drugs in experimental. S. mansoni in mice
21. A colourimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases
22. Effect of praziquantel on some aspects of cabohydrate metabolism in mice infected with S. mansoni
23. Recovery of the hepatic carcinogen-metabolizing capacity in schistosome-infected mice after treatment with praziquantel
24. Schistosomiasis induced changes in glutathione levels and glutathione reductase/glutathione s-transferase activities in human liver
25. Different levels of S. mansoni infection induced changes in drug-metabolizing enzymes
26. Biochemical study on the effect of oral antibilharzial drug administration on serum enyzmatic profile and some organic constituents in rats
27. Microsomal triphosphopyridine nucleotide-cytochrome C reductase of liver